I was diagnosed with RRMS in March 2019. Since I have had two relapses (December 18) and (March 19) I have been told that I am starting DMTs in May.
The Hospital phoned me yesterday advising that the EMA had restricted use of Lemtrada whilst they review potential new side effects.
I was scheduled to start Lemtrada infusions on the 13th May, but the hospital now said that it MAY be Ocrelizumab.
Hospital want to see me tomorrow to discuss treatment options but this has completely thrown me.
I am struggling with fatigue, working full time and the commute into London.
Browse categories and add by clicking on them
You can remove current categories below by clicking the ‘x’.